These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 33016643)

  • 1. The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways.
    Tian XY; Li J; Liu TH; Li DN; Wang JJ; Zhang H; Deng ZL; Chen FJ; Cai JP
    Cancer Med; 2020 Nov; 9(22):8612-8623. PubMed ID: 33016643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway.
    Huang L; Chen S; Fan H; Ai F; Sheng W
    J Cell Physiol; 2020 May; 235(5):4834-4842. PubMed ID: 31643092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathway.
    Guo Y; Zhang T; Shi Y; Zhang J; Li M; Lu F; Zhang J; Chen X; Ding S
    Helicobacter; 2020 Feb; 25(1):e12665. PubMed ID: 31657090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
    Ye Q; Cai W; Zheng Y; Evers BM; She QB
    Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA PlncRNA-1 Promotes Colorectal Cancer Cell Progression by Regulating the PI3K/Akt Signaling Pathway.
    Song W; Mei JZ; Zhang M
    Oncol Res; 2018 Mar; 26(2):261-268. PubMed ID: 28835319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
    Tao Y; Han T; Zhang T; Sun C
    Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
    Li X; Liang L; Huang L; Ma X; Li D; Cai S
    Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer.
    Ding C; Tang W; Wu H; Fan X; Luo J; Feng J; Wen K; Wu G
    Cancer Lett; 2019 Feb; 442():383-395. PubMed ID: 30472186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA SNHG20 promotes colorectal cancer cell proliferation, migration and invasion via miR‑495/STAT3 axis.
    Wang Y; Fu J; Yang L; Liang Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway.
    Pan Y; Cheung ST; Tong JHM; Tin KY; Kang W; Lung RWM; Wu F; Li H; Ng SSM; Mak TWC; To KF; Chan AWH
    J Transl Med; 2018 Jun; 16(1):150. PubMed ID: 29866109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBX3 promotes migration and invasion of colorectal cancer cells via activation of MAPK/ERK signaling pathway.
    Han HB; Gu J; Ji DB; Li ZW; Zhang Y; Zhao W; Wang LM; Zhang ZQ
    World J Gastroenterol; 2014 Dec; 20(48):18260-70. PubMed ID: 25561793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.